Chemotherapy plus local therapy improved overall survival and disease-free survival when compared to local therapy alone.

The UK’s health technology assessor the National Institute for Health and Care Excellence (NICE) has recommended brentuximab ...

From today, adults with advanced Hodgkin lymphoma have access to a new treatment, after we recommended brentuximab vedotin (brand name Adcetris) in combination with other therapies for routine NHS use ...

New treatment for advanced blood cancer recommended for use on NHS - It is estimated that about 800 people with Hodgkin ...

AVA6000 Phase 1b expansion cohorts enrolling with data targeted for later in 2025AVA6103 IND-enabling studies underway with a Phase 1 trial ...

Patients on Adcetris and chemo had better progression-free and overall survival after six years of follow-up compared to those on chemo only.

The relentless efforts of Cuban doctor Miguel Ángel Ruano Sánchez to improve the health of young Damir Ortiz Ramírez have ...